摘要
本文用参、芪口服液治疗冠心病23例。治疗后,心绞痛发作次数明显减少,主要心气虚症状明显好转;心电图总有效率为45％;药前左心功能异常者药后改善明显,PEP/LVET值由药前0.4255±0.0117降至O.3824±0.0134(M±SE,P<0.05);全血粘度、红细胞压积及纤维蛋白原含量无明显改变。提示参、芪口服液可缓解心绞痛症状,提高左心功能。本文还对益气法及活血化瘀法治疗冠心病的不同特点进行了探讨。
23 patients with coronary heart disease were treated with shenqi (codonopsis pilosula and astragalus) oral solution (SOS). The results showed: 1. The frequency of angina pectoris and the chief symptoms palpitation, shortness of breath and weakness, etc. were improved significantly. 2. The total effective rate of ischemic ST-T changes was 45％. 3. The left ventricular function was improved markedly in patients with abnormal cardiac function, the PEP/LVET ratio was decreased from 0.4255±0.0117 (M±SE) (pretreatment) to 0.3824±0.0134 (M±SE) (posttreatment) (P<0.05). 4. The whole blood viscosity, hematocrit and fibrinogen were no changes after treatment. These results suggested that the SOS had the effects on improvement of angina pectoris and left heart function The different effects between replenishing-Oi and promoting blood circulation on treating CHD are discussed
出处
《北京医学》
CAS
北大核心
1990年第1期33-35,共3页
Beijing Medical Journal
